Patents by Inventor Thomas Herz

Thomas Herz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220347780
    Abstract: A soldering nozzle (100) for selectively soldering assemblies by means of molten solder supplied through a soldering nozzle (100) from a solder bath. The soldering nozzle (100) is designed as a deep-drawn part. A method for the production of a soldering nozzle (100) is specified as well, including the provision of a blank (401); the drawing of the blank (401) through at least one female die (411, 421) by means of at least one male die (413, 422, 431) to produce an oblong shape (439) of locally annular or substantially annular cross-section, with a first end (436) corresponding to an action point of the male die (413, 422, 431) and a second end (437) corresponding to an introduction cross-section of the male die (413, 422, 431), the cross-section preferably increasing from the first end (436) towards the second end (437); and the formation of an opening (446) at the tip end (436).
    Type: Application
    Filed: July 18, 2022
    Publication date: November 3, 2022
    Inventors: Thomas Herz, Andreas Reinhardt, Markus Walter
  • Publication number: 20210060677
    Abstract: A soldering nozzle (100) for selectively soldering assemblies by means of molten solder supplied through a soldering nozzle (100) from a solder bath. The soldering nozzle (100) is designed as a deep-drawn part. A method for the production of a soldering nozzle (100) is specified as well, including the provision of a blank (401); the drawing of the blank (401) through at least one female die (411, 421) by means of at least one male die (413, 422, 431) to produce an oblong shape (439) of locally annular or substantially annular cross-section, with a first end (436) corresponding to an action point of the male die (413, 422, 431) and a second end (437) corresponding to an introduction cross-section of the male die (413, 422, 431), the cross-section preferably increasing from the first end (436) towards the second end (437); and the formation of an opening (446) at the tip end (436).
    Type: Application
    Filed: July 30, 2020
    Publication date: March 4, 2021
    Inventors: Thomas Herz, Andreas Reinhardt, Markus Walter
  • Patent number: 10201866
    Abstract: A soldering apparatus for selective soldering, comprising a solder bath for holding the molten solder at least one solder nozzle a solder pump for conveying solder from the solder bath through the solder nozzle a movement device for the relative movement of the solder nozzle and an assembly to be soldered wherein several solder nozzles are provided in several solder nozzle assemblies, with each solder nozzle assembly having one or more solder nozzles and wherein each solder nozzle assembly may be assigned an assembly, and the movement device is designed for synchronous movement of the several solder nozzle assemblies relative to the respective assemblies in the horizontal X-Y plane, and the soldering machine is so designed that the individual solder nozzle assemblies and the respective assemblies may be moved towards one another and independently of one another in the vertical direction (Z-direction) by means of a coupling device.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: February 12, 2019
    Assignee: SEHO SYSTEMTECHNIK GMBH
    Inventors: Bernd Dreikorn, Thomas Herz, Reiner Zoch, Markus Walter
  • Publication number: 20160215348
    Abstract: The present invention relates to the utilization of one or more genes selected from the group comprising ZFP64, DPP3, CCDC43, HIST2H4A/B, KDELC2 and MICALL1 as biomarkers for HDAC inhibitor treatment. The expression and/or change of the aforementioned genes are preferably determined via the respective corresponding mRNA or one or more proteins expressed by the aforementioned genes.
    Type: Application
    Filed: May 22, 2014
    Publication date: July 28, 2016
    Applicant: 4SC AG
    Inventors: Hella KOHLHOF, Thomas HERZ, Robert DOBLHOFER, Thomas BECKERS (Deceased), Astrid ZIMMERMANN, Marina MOLLENHAUER-THEIN, Markus BOEHM, Volker GEKELER, Hans-Peter HOFMANN, Thomas MAIER, Eike STAUB, Timo WITTENBERGER, Martin ELMLINGER
  • Publication number: 20150343546
    Abstract: The present invention relates to a method and an apparatus for cleaning a solder nozzle, together with a soldering apparatus. In order to facilitate thorough and easy cleaning, impurities on the solder nozzle are removed by ultrasound from an ultra-sonic source.
    Type: Application
    Filed: December 13, 2013
    Publication date: December 3, 2015
    Inventors: Thomas Herz, Gerald Schmitt, Reiner Zoch, Markus Walter
  • Publication number: 20150298233
    Abstract: A soldering apparatus for selective soldering, comprising a solder bath for holding the molten solder at least one solder nozzle a solder pump for conveying solder from the solder bath through the solder nozzle a movement device for the relative movement of the solder nozzle and an assembly to be soldered wherein several solder nozzles are provided in several solder nozzle assemblies, with each solder nozzle assembly having one or more solder nozzles and wherein each solder nozzle assembly may be assigned an assembly, and the movement device is designed for synchronous movement of the several solder nozzle assemblies relative to the respective assemblies in the horizontal X-Y plane, and the soldering machine is so designed that the individual solder nozzle assemblies and the respective assemblies may be moved towards one another and independently of one another in the vertical direction (Z-direction) by means of a coupling device.
    Type: Application
    Filed: December 5, 2013
    Publication date: October 22, 2015
    Inventors: Bernd Dreikorn, Thomas Herz, Reiner Zoch, Markus Walter
  • Publication number: 20110172241
    Abstract: The present invention relates to compounds of the general formulas (I), (Ia) and (II) and salts and physiologically functional derivatives thereof, wherein the substituents —Y are attached to the 5- or 6-position of the benzazole.
    Type: Application
    Filed: March 23, 2011
    Publication date: July 14, 2011
    Applicant: 4SC AG
    Inventors: Thomas HERZ, Rolf KRAUSS, Michael KUBBUTAT, Martin LANG, Christoph SCHAECHTELE, Stefan TASLER, Frank TOTZKE
  • Publication number: 20090270410
    Abstract: The present invention relates to compounds of the general formulas (I), (Ia) and (II) and salts and physiologically functional derivatives thereof, wherein the substituents -Y are attached to the 5- or 6-position of the benzazole.
    Type: Application
    Filed: July 7, 2009
    Publication date: October 29, 2009
    Applicant: 4SC AG
    Inventors: Thomas HERZ, Rolf KRAUSS, Michael KUBBUTAT, Martin LANG, Christoph SCHAECHTELE, Stefan TASLER, Frank TOTZKE
  • Patent number: 7576090
    Abstract: The present invention relates to compounds of the general formulas (I), (Ia) and (II) and salts and physiologically functional derivatives thereof, wherein the substituents —Y are attached to the 5- or 6-position of the benzazole.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: August 18, 2009
    Assignee: 4SC AG
    Inventors: Thomas Herz, Rolf Krauss, Michael Kubbutat, Martin Lang, Christoph Schaechtele, Stefan Tasler, Frank Totzke
  • Patent number: 7514460
    Abstract: The present invention relates to N2-heteroaryl-benzazole-2,(5 or 6)-diamine derivatives and compositions thereof as protein kinase inhibitors for the treatment of e.g. cancer.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: April 7, 2009
    Assignee: 4SC AG
    Inventors: Thomas Herz, Rolf Krauss, Michael Kubbutat, Martin Lang, Christoph Schaechtele, Stefan Tasler, Frank Totzke
  • Publication number: 20070149523
    Abstract: Compounds of formula (I) and salts and physiologically functional derivatives thereof, wherein R2 is attached at the 4- or 5-position of the thiazole ring and is hydrogen, alkyl, halogen, cyano, alkoxy, haloalkoxy, or alkylamino; X independently represents a divalent linkage group selected from S, O, NR4, SO, or SO2; R4 is hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, or heterocyclyl; R1 is attached at the 4- or 5-position of the thiazole ring and independently represents a group of formula (II): ?wherein the dotted line represents a single or double bond; * indicates the point of attachment to the thiazole ring; and n is 1, 2, or 3. Also disclosed are pharmaceutical compositions comprising the above compounds and method of treatments for cancer and other diseases.
    Type: Application
    Filed: November 14, 2006
    Publication date: June 28, 2007
    Inventors: Jan Ehlert, Thomas Herz, Rolf Krauss, Micheal Kubbutat, Martin Lang, Stefano Pegoraro, Christoph Schachtele, Frank Totzke, Ute Zirrgiebel
  • Publication number: 20070021446
    Abstract: The present invention relates to compounds of the general formula (I) and salts, prodrugs, and stereoisomers thereof, wherein Y independently represents S, O, NR2, SO, SO2; A independently represents a fife- or six-membered aromatic carbocycle or heterocycle and wherein R1 to R20 in formula (I) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties.
    Type: Application
    Filed: May 16, 2006
    Publication date: January 25, 2007
    Applicant: 4SC AG
    Inventors: Jan Ehlert, Thomas Herz, Rolf Krauss, Michael Kubbutat, Martin Lang, Wael Saeb, Christoph Schaechtele, Stefan Tasler, Frank Totzke, Ute Zirrgiebel
  • Publication number: 20060142570
    Abstract: The present invention relates to compounds of the general formulas (I), (Ia) and (II) and salts and physiologically functional derivatives thereof, wherein the substituents —Y are attached to the 5- or 6-position of the benzazole.
    Type: Application
    Filed: December 22, 2005
    Publication date: June 29, 2006
    Applicant: 4SC AG
    Inventors: Thomas Herz, Rolf Krauss, Michael Kubbutat, Martin Lang, Christoph Schaechtele, Stefan Tasler, Frank Totzke
  • Publication number: 20060135782
    Abstract: The present invention relates to N2-heteroaryl-benzazole-2,(5 or 6)-diamine derivatives and compositions thereof as protein kinase inhibitors for the treatment of e.g. cancer.
    Type: Application
    Filed: December 15, 2005
    Publication date: June 22, 2006
    Applicant: 4SC AG
    Inventors: Thomas Herz, Rolf Krauss, Michael Kubbutat, Martin Lang, Christoph Schaechtele, Stefan Tasler, Frank Totzke
  • Publication number: 20050143382
    Abstract: The present invention relates to furazanopyrazine derivatives of the general formula (I): wherein: R? represents —NR1R2 or —OR9 R? represents —NR5—NR3R4, —NR5—ORb, —O—NR3R4; wherein R1 to R9 in formula (I) represent independently of each other a variety of different substituents comprising alkyl, aryl, aralkyl, alkylaryl, heteroaryl groups and monofunctional moieties.
    Type: Application
    Filed: November 2, 2004
    Publication date: June 30, 2005
    Applicant: 4SC AG
    Inventors: Katharina Aulinger-Fuchs, Thomas Herz, Rolf Krauss, Michael Kubbatat, Martin Lang, Christoph Schachtele, Frank Totzke